The pediatric rheumatologist and nephrologist will co-lead kidney imaging studies with a multidisciplinary team studying pediatric lupus nephritis.
Seattle Children’s researchers and colleagues have identified a new driver of autoimmunity that may be relevant to many diseases, including lupus.
Seattle Children’s researchers revealed novel insights about PiCo, a brainstem region that aids the coordination of swallowing and breathing.
Seattle Children’s researchers and colleagues discovered why kids with allergic asthma fare better against COVID-19.
Our researchers are improving pediatric healthcare by leading and participating in hundreds of research projects.
Learn about our novel non-profit therapeutics development enterprise, devoted to envisioning and testing next-generation cell and gene therapies for pediatric diseases.
Take a virtual tour of the Research Division for an insider's view of our buildings, labs and collaborative spaces.
The Invent at Seattle Children’s Postdoctoral Scholars Program is an investment in training early career scientists historically underrepresented in or excluded from biotech in the development of therapeutics for childhood conditions. Learn more.
Our dedicated researchers are working relentlessly to improve treatments for more than 200 diseases and conditions to discover the most effective, least invasive and best options for the kids who need it most.
More than half of the kids who come to Seattle Children’s live with serious conditions that they will have for the rest of their lives. Research can give them a different future. Your support makes it possible.
By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.